Is it safe to take lemon balm or St. John's Wort with a Selective Serotonin Reuptake Inhibitor (SSRI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Lemon Balm and St. John's Wort with SSRIs

St. John's wort is absolutely contraindicated with SSRIs due to the risk of serotonin syndrome, while lemon balm should be avoided due to potential additive CNS depression effects. 1, 2, 3, 4

St. John's Wort: Absolute Contraindication

St. John's wort must never be taken concurrently with SSRIs. This combination creates a serious risk of serotonin syndrome, a potentially life-threatening condition. 1, 2, 3, 4

Mechanism of Interaction

  • St. John's wort acts as a serotonergic agent that can dangerously potentiate the effects of SSRIs 3, 4, 5
  • The FDA drug labels for both fluoxetine and sertraline explicitly warn against concomitant use with St. John's wort due to serotonin syndrome risk 3, 4
  • Documented case reports confirm serotonin syndrome when SSRIs (including sertraline and paroxetine) are combined with St. John's wort 5, 6

Clinical Manifestations of Serotonin Syndrome

Patients must be monitored for: 4

  • Mental status changes (agitation, hallucinations, delirium, coma)
  • Autonomic instability (tachycardia, labile blood pressure, hyperthermia, diaphoresis)
  • Neuromuscular symptoms (tremor, rigidity, myoclonus, hyperreflexia)
  • Gastrointestinal symptoms (nausea, vomiting, diarrhea)

Switching Between Medications

  • If transitioning from St. John's wort to an SSRI, monitor for at least 24-48 hours after discontinuing St. John's wort, as serotonin syndrome symptoms can emerge during this period 1
  • When discontinuing SSRIs to start St. John's wort, appropriate washout periods must be observed based on the specific SSRI's half-life 3

Additional Drug Interaction Concerns

Beyond serotonin syndrome, St. John's wort is a potent inducer of CYP3A4 and P-glycoprotein, which significantly decreases plasma concentrations of numerous medications including: 7, 1, 5

  • Oral contraceptives (risk of unintended pregnancy)
  • Immunosuppressants (risk of transplant rejection)
  • Anticoagulants (increased thrombotic risk)
  • HIV medications
  • Cancer chemotherapy agents

Lemon Balm: Not Recommended

Lemon balm should be avoided when taking SSRIs or other CNS-active medications. 7

Rationale for Avoidance

  • The Society for Perioperative Assessment and Quality Improvement (SPAQI) recommends holding lemon balm for 2 weeks before surgery due to evidence suggesting additive CNS depression when combined with sedatives 7
  • While the perioperative guideline specifically addresses sedatives and alcohol, the mechanism of additive CNS depression raises concern for interactions with SSRIs, which can also cause sedation 7

Clinical Considerations

  • The evidence for lemon balm interactions is less robust than for St. John's wort, but the potential for additive effects warrants caution 7
  • No specific studies have evaluated lemon balm safety with SSRIs, but the precautionary principle applies given the known CNS depressant effects 7

Common Pitfalls to Avoid

  • Patients often fail to disclose herbal supplement use: Explicitly ask about all supplements, including "natural" or over-the-counter products 1, 8
  • Assuming herbal products are safe because they're "natural": St. John's wort has serious, well-documented drug interactions that can be life-threatening 1, 5, 8
  • Lack of FDA regulation: St. John's wort preparations in the United States have no standardization of content or potency, making dosing unpredictable 1, 2
  • Underestimating interaction severity: Population studies have identified concerning rates of concurrent SSRI and St. John's wort use (11 cases identified in one Australian cohort), indicating this dangerous combination occurs in real-world practice 6

References

Guideline

St. John's Wort for Depression and Anxiety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

St. John's Wort for Mild-to-Moderate Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.

International journal of clinical pharmacology and therapeutics, 2004

Research

Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.